Literature DB >> 21528488

Up-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior.

Yue Wang1, Li Dong, Heng Cui, Dan-hua Shen, Ying Wang, Xiao-hong Chang, Tian-yun Fu, Xue Ye, Yuan-yang Yao.   

Abstract

OBJECTIVE: Recently, a high frequency of mutations in mitochondrial DNA (mtDNA) has been detected in ovarian cancer. To explore the alterations of proteins in mitochondria in ovarian cancer, a pair of human ovarian carcinoma cell lines (SKOV3/SKOV3.ip1) with different metastatic potentials was examined.
METHODS: Cancer cells SKOV3.ip1 were derived from the ascitic tumor cells of nude mice bearing a tumor of ovarian cancer cells SKOV3. SKOV3.ip1 exhibited a higher degree of migration potential than its paired cell line SKOV3. The proteins in the mitochondria of these two cells were isolated and separated by 2-D gel electrophoresis. The differently expressed proteins were extracted and identified using matrix assisted laser desorption ionisation/time-of-flight/time-of-flight (MALDI-TOF/TOF), and finally a selected protein candidate was further investigated by immunohistochemistry (IHC) method in nude mice bearing tumor tissues of these two cells.
RESULTS: A total of 35 spots with different expressions were identified between the two cells using 2D-polyacrylamide gel electrophoresis (PAGE) approach. Among them, 17 spots were detected only in either SKOV3 or SKOV3.ip1 cells. Eighteen spots expressed different levels, with as much as a three-fold difference between the two cells. Twenty spots were analyzed using MALDI-TOF/TOF, and 11 of them were identified successfully; four were known to be located in mitochondria, including superoxide dismutase 2 (SOD2), fumarate hydratase (FH), mitochondrial ribosomal protein L38 (MRPL38), and mRNA turnover 4 homolog (MRTO4). An increased staining of SOD2 was observed in SKOV3.ip1 over that of SKOV3 in IHC analysis.
CONCLUSIONS: Our results indicate that the enhanced antioxidation and metabolic potentials of ovarian cancer cells might contribute to their aggressive and metastatic behaviors. The underlying mechanism warrants further study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528488      PMCID: PMC3087090          DOI: 10.1631/jzus.B1000192

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  25 in total

Review 1.  Mitochondria: releasing power for life and unleashing the machineries of death.

Authors:  Donald D Newmeyer; Shelagh Ferguson-Miller
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

2.  Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation.

Authors:  Kip M Connor; Sita Subbaram; Kevin J Regan; Kristin K Nelson; Joseph E Mazurkiewicz; Peter J Bartholomew; Andrew E Aplin; Yu-Tzu Tai; Julio Aguirre-Ghiso; Sonia C Flores; J Andres Melendez
Journal:  J Biol Chem       Date:  2005-02-08       Impact factor: 5.157

3.  Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis.

Authors:  Kristin K Nelson; Aparna C Ranganathan; Jelriza Mansouri; Ana M Rodriguez; Kirwin M Providence; Joni L Rutter; Kevin Pumiglia; James A Bennett; J Andres Melendez
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

4.  Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases.

Authors:  R Salzman; K Kanková; L Pácal; J Tomandl; Z Horáková; R Kostrica
Journal:  Neoplasma       Date:  2007       Impact factor: 2.575

5.  Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species.

Authors:  Yongqiang Chen; Eileen McMillan-Ward; Jiming Kong; Sara J Israels; Spencer B Gibson
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

6.  Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells.

Authors:  Michael J Hitchler; Kornwipa Wikainapakul; Lei Yu; Kristy Powers; Watcharee Attatippaholkun; Frederick E Domann
Journal:  Epigenetics       Date:  2006-09-13       Impact factor: 4.528

7.  Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species.

Authors:  Sunil Sudarshan; Carole Sourbier; Hye-Sik Kong; Karen Block; Vladimir A Valera Romero; Youfeng Yang; Cynthia Galindo; Mehdi Mollapour; Bradley Scroggins; Norman Goode; Min-Jung Lee; Campbell W Gourlay; Jane Trepel; W Marston Linehan; Len Neckers
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

8.  Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets.

Authors:  Y-W Lin; P D Aplan
Journal:  Leukemia       Date:  2007-04-12       Impact factor: 11.528

9.  Association between manganese superoxide dismutase polymorphism and risk of lung cancer.

Authors:  Jasmina Zejnilovic; Nuriye Akev; Hulya Yilmaz; Turgay Isbir
Journal:  Cancer Genet Cytogenet       Date:  2009-02

10.  Association of decreased mitochondrial DNA content with ovarian cancer progression.

Authors:  Y Wang; V W S Liu; W C Xue; A N Y Cheung; H Y S Ngan
Journal:  Br J Cancer       Date:  2006-10-03       Impact factor: 7.640

View more
  7 in total

Review 1.  Mitochondrial ribosomes in cancer.

Authors:  Hyun-Jung Kim; Priyanka Maiti; Antoni Barrientos
Journal:  Semin Cancer Biol       Date:  2017-04-23       Impact factor: 15.707

Review 2.  Potential of Mitochondrial Ribosomal Genes as Cancer Biomarkers Demonstrated by Bioinformatics Results.

Authors:  Shunchao Bao; Xinyu Wang; Mo Li; Zhao Gao; Dongdong Zheng; Dihan Shen; Linlin Liu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

3.  Structure of the large ribosomal subunit from human mitochondria.

Authors:  Alan Brown; Alexey Amunts; Xiao-Chen Bai; Yoichiro Sugimoto; Patricia C Edwards; Garib Murshudov; Sjors H W Scheres; V Ramakrishnan
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

4.  MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.

Authors:  Haoya Xu; Ruoyao Zou; Feifei Li; Jiyu Liu; Nannan Luan; Shengke Wang; Liancheng Zhu
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

5.  Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer.

Authors:  Jun-Jun Qiu; Xiao-Jing Lin; Xiao-Yan Tang; Ting-Ting Zheng; Ying-Ying Lin; Ke-Qin Hua
Journal:  Int J Biol Sci       Date:  2018-11-01       Impact factor: 6.580

6.  MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.

Authors:  Zuo Tao; Huandan Suo; Lei Zhang; Zining Jin; Zhen Wang; Danyu Wang; Ming Wu; Nanxi Peng; Yujie Zhao; Bo Chen
Journal:  Onco Targets Ther       Date:  2020-11-27       Impact factor: 4.147

7.  Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition.

Authors:  Xiaojing Lin; Xiaoyan Tang; Tingting Zheng; Junjun Qiu; Keqin Hua
Journal:  J Ovarian Res       Date:  2020-04-25       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.